Serum markers in prostate cancer detection.

Summary, in English

Prostate-specific antigen (PSA) testing provides significant benefits by reducing prostate cancer mortality, but also leads to important harms by detecting clinically insignificant cancers. Hence, there are urgent needs for complementary tools for middle-aged men with modest PSA elevations in blood. This review includes research on prostate cancer biomarkers in blood published from March 2013 through August 2014.

• Författare: Ola Bratt; Hans Lilja
• Avdelning/ar: Urologisk cancerforskning, Malmö; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation; Klinisk kemi, Malmö; EpiHealth: Epidemiology for Health
• Publiceringsår: 2015
• Språk: Engelska
• Sidor: 59-64
• Publikation/Tidskrift/Serie: Current Opinion in Urology
• Volym: 25
• Issue: 1
• Länkar: http://www.ncbi.nlm.nih.gov/pubmed/25393274?dopt=Abstract; http://dx.doi.org/10.1097/MOU.0000000000000128
• Dokumenttyp: Artikel i tidskrift
• Förlag: Lippincott Williams & Wilkins
• Ämne: Cancer and Oncology
• Status: Published
• Forskningsgrupp: Urological cancer, Malmö; Clinical Chemistry, Malmö
• ISBN/ISSN/Övrigt: ISSN: 0963-0643